Cardiovascular Outcomes in Trials of Oral Diabetes Medications, Archives of Internal Medicine, vol.168, issue.19, pp.2070-2080, 2008. ,
DOI : 10.1001/archinte.168.19.2070
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials, Diabetes, Obesity and Metabolism, vol.46, issue.3, pp.221-228, 2011. ,
DOI : 10.1111/j.1463-1326.2010.01349.x
Metformin Rapidly Increases Insulin Receptor Activation in Human Liver and Signals Preferentially through Insulin-Receptor Substrate-2, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.3, pp.1323-1332, 2003. ,
DOI : 10.1210/jc.2002-021394
Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-?? in mice, Diabetologia, vol.59, issue.Suppl 1, pp.339-349, 2011. ,
DOI : 10.1007/s00125-010-1937-z
Metabolic effects of metformin on glucose and lactate metabolism in noninsulin-dependent diabetes mellitus, J Clin Endocrinol Metab, vol.81, pp.4059-4067, 1996. ,
Mechanism by which metformin reduces glucose production in type 2 diabetes, Diabetes, vol.49, issue.12, pp.2063-2069, 2000. ,
DOI : 10.2337/diabetes.49.12.2063
Effects of metformin and thiazolidinediones on suppression of hepatic glucose production and stimulation of glucose uptake in type 2 diabetes: a systematic review, Diabetologia, vol.27, issue.3, pp.434-441, 2006. ,
DOI : 10.1007/s00125-006-0141-7
Metformin decreases gluconeogenesis by enhancing the pyruvate kinase flux in isolated rat hepatocytes, European Journal of Biochemistry, vol.119, issue.3, pp.1341-1348, 1993. ,
DOI : 10.1016/0014-5793(76)80865-4
URL : https://hal.archives-ouvertes.fr/inserm-00390262
Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin, Diabetes, vol.48, issue.6, pp.1251-1257, 1999. ,
DOI : 10.2337/diabetes.48.6.1251
Intrahepatic Mechanisms Underlying the Effect of Metformin in Decreasing Basal Glucose Production in Rats Fed a High-Fat Diet, Diabetes, vol.51, issue.1, pp.139-143, 2002. ,
DOI : 10.2337/diabetes.51.1.139
Effects of Metformin on Lactate Uptake and Gluconeogenesis in the Perfused Rat Liver, Diabetes, vol.46, issue.9, pp.1406-1413, 1997. ,
DOI : 10.2337/diab.46.9.1406
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action, Journal of Clinical Investigation, vol.117, issue.5, pp.1422-1431, 2007. ,
DOI : 10.1172/JCI30558DS1
Accumulation of metformin by tissues of the normal and diabetic mouse, Xenobiotica, vol.37, issue.1, pp.49-57, 1994. ,
DOI : 10.1016/S0168-8227(88)80022-6
Role of AMP-activated protein kinase in mechanism of metformin action, Journal of Clinical Investigation, vol.108, issue.8, pp.1167-1174, 2001. ,
DOI : 10.1172/JCI13505
AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives, Acta Physiologica, vol.108, issue.Pt 1, pp.81-98, 2009. ,
DOI : 10.1111/j.1748-1716.2009.01970.x
URL : https://hal.archives-ouvertes.fr/inserm-00363222
AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase, Science, vol.332, issue.6036, pp.1433-1435, 2011. ,
DOI : 10.1126/science.1200094
Structure of mammalian AMPK and its regulation by ADP, Nature, vol.50, issue.7342, pp.230-233, 2011. ,
DOI : 10.1038/nature09932
Neither LKB1 Nor AMPK Are the Direct Targets of Metformin, Gastroenterology, vol.131, issue.3, pp.973-975, 2006. ,
DOI : 10.1053/j.gastro.2006.07.032
Dimethylbiguanide Inhibits Cell Respiration via an Indirect Effect Targeted on the Respiratory Chain Complex I, Journal of Biological Chemistry, vol.275, issue.1, pp.223-228, 2000. ,
DOI : 10.1074/jbc.275.1.223
URL : https://hal.archives-ouvertes.fr/inserm-00390049
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain, Biochemical Journal, vol.348, issue.3, pp.607-614, 2000. ,
DOI : 10.1042/bj3480607
Thiazolidinediones, Like Metformin, Inhibit Respiratory Complex I: A Common Mechanism Contributing to Their Antidiabetic Actions?, Diabetes, vol.53, issue.4, pp.1052-1059, 2004. ,
DOI : 10.2337/diabetes.53.4.1052
Metformin Prevents High-Glucose-Induced Endothelial Cell Death Through a Mitochondrial Permeability Transition-Dependent Process, Diabetes, vol.54, issue.7, pp.2179-2187, 2005. ,
DOI : 10.2337/diabetes.54.7.2179
URL : https://hal.archives-ouvertes.fr/inserm-00388755
Methyl succinate antagonises biguanide-induced AMPK-activation and death of pancreatic ??-cells through restoration of mitochondrial electron transfer, British Journal of Pharmacology, vol.108, issue.Part 3, pp.1031-1043, 2007. ,
DOI : 10.1038/sj.bjp.0707189
Neuroprotective Role of Antidiabetic Drug Metformin Against Apoptotic Cell Death in Primary Cortical Neurons, Journal of Molecular Neuroscience, vol.279, issue.Suppl 4bis, pp.77-87, 2008. ,
DOI : 10.1007/s12031-007-9002-1
URL : https://hal.archives-ouvertes.fr/inserm-00388540
Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status . Diabetologia . in the press, 2011. ,
Obligatory role of membrane events in the regulatory effect of metformin on the respiratory chain function, Biochemical Pharmacology, vol.63, issue.7, pp.1259-1272, 2002. ,
DOI : 10.1016/S0006-2952(02)00858-4
URL : https://hal.archives-ouvertes.fr/inserm-00389975
study, Biochemical Journal, vol.382, issue.3, pp.877-884, 2004. ,
DOI : 10.1042/BJ20040885
URL : https://hal.archives-ouvertes.fr/inserm-00387151
Photoaffinity cross-linking of oligomycin-sensitive ATPase from beef heart mitochondria by 3???-arylazido-8-azido ATP, Biochemical and Biophysical Research Communications, vol.111, issue.2, pp.732-739, 1983. ,
DOI : 10.1016/0006-291X(83)90366-2
The ROS Production Induced by a Reverse-Electron Flux at Respiratory-Chain Complex 1 is Hampered by Metformin, Journal of Bioenergetics and Biomembranes, vol.79, issue.1, pp.33-42, 2006. ,
DOI : 10.1007/s10863-006-9003-8
URL : https://hal.archives-ouvertes.fr/inserm-00388702
Metformin selectively attenuates mitochondrial H2O2 emission without affecting respiratory capacity in skeletal muscle of obese rats, Free Radical Biology and Medicine, vol.49, issue.6, pp.1082-1087, 2010. ,
DOI : 10.1016/j.freeradbiomed.2010.06.022
The effects of glucose, insulin and metformin on the order parameters of isolated red cell membranes, Biochemical Pharmacology, vol.43, issue.6, pp.1185-1194, 1992. ,
DOI : 10.1016/0006-2952(92)90491-Z
Action of metformin on erythrocyte membrane fluidity in vitro and in vivo, European Journal of Pharmacology, vol.337, issue.1, 1997. ,
DOI : 10.1016/S0014-2999(97)01287-9
Use of Cells Expressing ?? Subunit Variants to Identify Diverse Mechanisms of AMPK Activation, Cell Metabolism, vol.11, issue.6, pp.554-565, 2010. ,
DOI : 10.1016/j.cmet.2010.04.001
The Kinase LKB1 Mediates Glucose Homeostasis in Liver and Therapeutic Effects of Metformin, Science, vol.310, issue.5754, pp.1642-1646, 2005. ,
DOI : 10.1126/science.1120781
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism, Nature, vol.50, issue.7062, pp.1109-1111, 2005. ,
DOI : 10.1111/j.1432-1033.2004.04372.x
Hepatic Glucose Sensing via the CREB Coactivator CRTC2, Science, vol.319, issue.5868, pp.1402-1405, 2008. ,
DOI : 10.1126/science.1151363
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5, Journal of Endocrinology, vol.205, issue.1, 2010. ,
DOI : 10.1677/JOE-09-0345
A fasting inducible switch modulates gluconeogenesis via activator/coactivator exchange, Nature, vol.104, issue.7219, pp.269-273, 2008. ,
DOI : 10.1038/nature07349
Metformin and Insulin Suppress Hepatic Gluconeogenesis through Phosphorylation of CREB Binding Protein, Cell, vol.137, issue.4, pp.635-646, 2009. ,
DOI : 10.1016/j.cell.2009.03.016
Metformin Inhibits Hepatic Gluconeogenesis Through AMP-Activated Protein Kinase-Dependent Regulation of the Orphan Nuclear Receptor SHP, Diabetes, vol.57, issue.2, pp.306-314, 2008. ,
DOI : 10.2337/db07-0381
Role of KLF15 in Regulation of Hepatic Gluconeogenesis and Metformin Action, Diabetes, vol.59, issue.7, pp.1608-1615, 2010. ,
DOI : 10.2337/db09-1679
Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state, Journal of Clinical Investigation, vol.120, issue.7, pp.2355-2369, 2010. ,
DOI : 10.1172/JCI40671DS1
URL : https://hal.archives-ouvertes.fr/inserm-00495746
An energetic tale of AMPK-independent effects of metformin, Journal of Clinical Investigation, vol.120, issue.7, pp.2267-2270, 2010. ,
DOI : 10.1172/JCI43661
Metformin reverses fatty liver disease in obese, leptin-deficient mice, Nat Med, vol.6, pp.998-1003, 2000. ,
Comparative therapeutic effects of metformin and vitamin E in a model of non-alcoholic steatohepatitis in the young rat, European Journal of Pharmacology, vol.604, issue.1-3, pp.125-131, 2009. ,
DOI : 10.1016/j.ejphar.2008.12.013
Metformin in non-alcoholic steatohepatitis, The Lancet, vol.358, issue.9285, pp.893-894, 2001. ,
DOI : 10.1016/S0140-6736(01)06042-1
Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial, Alimentary Pharmacology and Therapeutics, vol.49, issue.1, pp.23-28, 2004. ,
DOI : 10.1073/pnas.95.25.14751
AMP-activated Protein Kinase Is Required for the Lipid-lowering Effect of Metformin in Insulin-resistant Human HepG2 Cells, Journal of Biological Chemistry, vol.279, issue.46, pp.47898-47905, 2004. ,
DOI : 10.1074/jbc.M408149200
Short-Term Overexpression of a Constitutively Active Form of AMP-Activated Protein Kinase in the Liver Leads to Mild Hypoglycemia and Fatty Liver, Diabetes, vol.54, issue.5, pp.1331-1339, 2005. ,
DOI : 10.2337/diabetes.54.5.1331
AMP-activated Protein Kinase Inhibits the Glucose-activated Expression of Fatty Acid Synthase Gene in Rat Hepatocytes, Journal of Biological Chemistry, vol.273, issue.24, pp.14767-14771, 1998. ,
DOI : 10.1074/jbc.273.24.14767
AMP-activated Protein Kinase Regulates HNF4?? Transcriptional Activity by Inhibiting Dimer Formation and Decreasing Protein Stability, Journal of Biological Chemistry, vol.278, issue.30, pp.27495-27501, 2003. ,
DOI : 10.1074/jbc.M304112200
Mechanism for Fatty Acid "Sparing" Effect on Glucose-induced Transcription: REGULATION OF CARBOHYDRATE-RESPONSIVE ELEMENT-BINDING PROTEIN BY AMP-ACTIVATED PROTEIN KINASE, Journal of Biological Chemistry, vol.277, issue.6, pp.3829-3835, 2002. ,
DOI : 10.1074/jbc.M107895200
Hepatocyte Nuclear Factor-4?? Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase, Diabetes, vol.50, issue.7, pp.1515-1521, 2001. ,
DOI : 10.2337/diabetes.50.7.1515
Regulation of Transcription by AMP-activated Protein Kinase: PHOSPHORYLATION OF p300 BLOCKS ITS INTERACTION WITH NUCLEAR RECEPTORS, Journal of Biological Chemistry, vol.276, issue.42, pp.38341-38344, 2001. ,
DOI : 10.1074/jbc.C100316200
Metformin Inhibits Nuclear Receptor TR4-Mediated Hepatic Stearoyl-CoA Desaturase 1 Gene Expression With Altered Insulin Sensitivity, Diabetes, vol.60, issue.5, pp.1493-1503, 2011. ,
DOI : 10.2337/db10-0393
Tubular Injury in a Rat Model of Type 2 Diabetes Is Prevented by Metformin, Diabetes, vol.60, issue.3, pp.981-992, 2011. ,
DOI : 10.2337/db10-0655
Metformin prevents experimental gentamicin-induced nephropathy by a mitochondria-dependent pathway, Kidney International, vol.77, issue.10, pp.861-869, 2010. ,
DOI : 10.1038/ki.2010.11
URL : https://hal.archives-ouvertes.fr/inserm-00628475
Metformin against TGF??-induced epithelial-to-mesenchymal transition (EMT): From cancer stem cells to aging-associated fibrosis, Cell Cycle, vol.9, issue.22, pp.4461-4468, 2010. ,
DOI : 10.4161/cc.9.22.14048
Metformin induces suppression of NAD(P)H oxidase activity in podocytes, Biochemical and Biophysical Research Communications, vol.393, issue.2, pp.268-273, 2010. ,
DOI : 10.1016/j.bbrc.2010.01.119
Insulin and metformin may prevent renal injury in young type 2 diabetic Goto???Kakizaki rats, European Journal of Pharmacology, vol.653, issue.1-3, 2011. ,
DOI : 10.1016/j.ejphar.2010.11.029
Effect of fenofibrate and metformin on lipotoxicity in OLETF rat kidney, Beijing Da Xue Xue Bao, vol.38, pp.170-175, 2006. ,
Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis, Proceedings of the National Academy of Sciences, vol.108, issue.6, pp.2462-2467, 2011. ,
DOI : 10.1073/pnas.1011498108
Review: Metformin: Potential benefits and use in chronic kidney disease, Nephrology, vol.14, issue.3, pp.412-418, 2010. ,
DOI : 10.1111/j.1440-1797.2010.01328.x
Metformin: The Safest Hypoglycaemic Agent in Chronic Kidney Disease?, Nephron Clinical Practice, vol.118, issue.4, pp.380-383, 2011. ,
DOI : 10.1159/000323739
Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations, Diabetes Care, vol.33, issue.6, pp.1291-1293, 2010. ,
DOI : 10.2337/dc09-1284
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management, Annals of Internal Medicine, vol.139, issue.10, pp.824-834, 2003. ,
DOI : 10.7326/0003-4819-139-10-200311180-00010
Reduced cardiovascular morbidity and mortality associated with metformin use in subjects with Type 2 diabetes, Diabetic Medicine, vol.281, issue.Series B, pp.497-502, 2005. ,
DOI : 10.1111/j.1464-5491.2005.01448.x
Decreased mortality associated with the use of metformin compared with sulfonylurea monotherapy in type 2 diabetes . Diabetes Care, pp.2244-2248, 2002. ,
Metformin improves cardiac function in a non-diabetic rat model of post-MI heart failure, Am J Physiol Heart Circ Physiol, 2011. ,
The Effect of Metformin on the Myocardial Tolerance to Ischemia-Reperfusion Injury in the Rat Model of Diabetes Mellitus Type II, Experimental Diabetes Research, vol.3, issue.4, p.907496, 2011. ,
DOI : 10.2337/diabetes.54.7.2227
AMP-Activated Protein Kinase Activation during Cardioplegia-Induced Hypoxia/Reoxygenation Injury Attenuates Cardiomyocytic Apoptosis via Reduction of Endoplasmic Reticulum Stress, Mediators of Inflammation, vol.270, issue.4, p.130636, 2010. ,
DOI : 10.1038/sj.cdd.4401984
Energetic myocardial metabolism and oxidative stress: Let's make them our friends in the fight against heart failure, Biomedicine & Pharmacotherapy, vol.64, issue.3, pp.203-207, 2010. ,
DOI : 10.1016/j.biopha.2009.10.002
Optimizing Cardiac Fatty Acid and Glucose Metabolism as an Approach to Treating Heart Failure, Seminars in Cardiothoracic and Vascular Anesthesia, vol.10, issue.3, pp.228-230, 2006. ,
DOI : 10.1177/1089253206291150
Effect of metformin therapy on cardiac function and survival in a volume-overload model of heart failure in rats, Clinical Science, vol.277, issue.1, pp.29-41, 2011. ,
DOI : 10.1097/HJH.0b013e3282f9b58a
Metformin: safety in cardiac patients, Postgraduate Medical Journal, vol.86, issue.1016, pp.99-102, 2010. ,
DOI : 10.1136/hrt.2009.173773
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure . Diabetes Care, pp.2345-2351, 2005. ,
Wrongfully accused: metformin use in heart failure, Expert Review of Cardiovascular Therapy, vol.9, issue.2, pp.147-150, 2011. ,
DOI : 10.1586/erc.10.186
Metformin Use and Mortality Among Patients With Diabetes and Atherothrombosis<alt-title>Metformin Use With Diabetes and Atherothrombosis</alt-title>, Archives of Internal Medicine, vol.170, issue.21, pp.1892-1899, 2010. ,
DOI : 10.1001/archinternmed.2010.409
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis . Diabetes Care, pp.1224-1229, 2010. ,
Improvement of Cardiac Functions by Chronic Metformin Treatment Is Associated With Enhanced Cardiac Autophagy in Diabetic OVE26 Mice, Diabetes, vol.60, issue.6, pp.1770-1778, 2011. ,
DOI : 10.2337/db10-0351
Activation of AMP-Activated Protein Kinase by Metformin Improves Left Ventricular Function and Survival in Heart Failure, Circulation Research, vol.104, issue.3, pp.403-411, 2009. ,
DOI : 10.1161/CIRCRESAHA.108.190918
Metformin Prevents Progression of Heart Failure in Dogs: Role of AMP-Activated Protein Kinase, Circulation, vol.119, issue.19, pp.2568-2577, 2009. ,
DOI : 10.1161/CIRCULATIONAHA.108.798561
Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats, Clinical and Experimental Pharmacology and Physiology, vol.15, issue.1, pp.55-62, 2011. ,
DOI : 10.1111/j.1440-1681.2010.05461.x
Nitric Oxide, NAD(P)H Oxidase, and Atherosclerosis, Antioxidants & Redox Signaling, vol.11, issue.7, pp.1711-1731, 2009. ,
DOI : 10.1089/ars.2008.2403
Estradiol-Mediated Endothelial Nitric Oxide Synthase Association With Heat Shock Protein 90 Requires Adenosine Monophosphate-Dependent Protein Kinase, Circulation, vol.111, issue.25, pp.3473-3480, 2005. ,
DOI : 10.1161/CIRCULATIONAHA.105.546812
Metformin decreases intracellular production of reactive oxygen species in aortic endothelial cells, Metabolism, vol.54, issue.6, pp.829-834, 2005. ,
DOI : 10.1016/j.metabol.2005.01.029
Activation of AMP-Activated Protein Kinase Reduces Hyperglycemia-Induced Mitochondrial Reactive Oxygen Species Production and Promotes Mitochondrial Biogenesis in Human Umbilical Vein Endothelial Cells, Diabetes, vol.55, issue.1, pp.120-127, 2006. ,
DOI : 10.2337/diabetes.55.01.06.db05-0943
Evidence that pioglitazone, metformin and pentoxifylline are inhibitors of glycation, Clinica Chimica Acta, vol.301, issue.1-2, pp.65-77, 2000. ,
DOI : 10.1016/S0009-8981(00)00327-2
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial, Journal of Internal Medicine, vol.29, issue.1, pp.100-109, 2005. ,
DOI : 10.1053/meta.2001.28078
AMP-ACTIVATED PROTEIN KINASE ACTIVATION AS A STRATEGY FOR PROTECTING VASCULAR ENDOTHELIAL FUNCTION, Clinical and Experimental Pharmacology and Physiology, vol.277, issue.5-6, pp.535-545, 2008. ,
DOI : 10.1161/01.HYP.0000221429.94591.72
nsulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility, Cochrane Database Syst Rev, p.3053, 2010. ,
Consensus on infertility treatment related to polycystic ovary syndrome, Hum Reprod, vol.23, pp.462-477, 2008. ,
Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review, Endocrine Reviews, vol.30, issue.1, 2009. ,
DOI : 10.1210/er.2008-0030
Gene, The Journal of Clinical Endocrinology & Metabolism, vol.93, issue.3, pp.792-800, 2008. ,
DOI : 10.1210/jc.2007-1736
Diabetes and cancer: a consensus report . Diabetes Care, pp.1674-1685, 2010. ,
Metformin: Taking away the candy for cancer?, European Journal of Cancer, vol.46, issue.13, pp.2369-2380, 2010. ,
DOI : 10.1016/j.ejca.2010.06.012
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes, Diabetologia, vol.23, issue.9, pp.1766-1777, 2009. ,
DOI : 10.1007/s00125-009-1440-6
Metformin and reduced risk of cancer in diabetic patients, BMJ, vol.330, issue.7503, pp.1304-1305, 2005. ,
DOI : 10.1136/bmj.38415.708634.F7
Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure, Diabetologia, vol.374, issue.5 Suppl B, pp.1631-1637, 2010. ,
DOI : 10.1007/s00125-010-1750-8
Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16, Diabetes Care, vol.33, issue.2, pp.322-326, 2010. ,
DOI : 10.2337/dc09-1380
New Users of Metformin Are at Low Risk of Incident Cancer: A cohort study among people with type 2 diabetes, Diabetes Care, vol.32, issue.9, pp.1620-1625, 2009. ,
DOI : 10.2337/dc08-2175
Long-term metformin use is associated with decreased risk of breast cancer . Diabetes Care, pp.1304-1308, 2010. ,
Antidiabetic Therapies Affect Risk of Pancreatic Cancer, Gastroenterology, vol.137, issue.2, pp.482-488, 2009. ,
DOI : 10.1053/j.gastro.2009.04.013
Metformin use and prostate cancer in Caucasian men: results from a population-based case???control study, Cancer Causes & Control, vol.164, issue.10, pp.1617-1622, 2009. ,
DOI : 10.1007/s10552-009-9407-y
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?, Molecular Cancer Therapeutics, vol.9, issue.5, pp.1092-1099, 2010. ,
DOI : 10.1158/1535-7163.MCT-09-1186
Insulin-Lowering Effects of Metformin in Women with Early Breast Cancer, Clinical Breast Cancer, vol.8, issue.6, pp.501-505, 2008. ,
DOI : 10.3816/CBC.2008.n.060
Prevention of pancreatic cancer induction in hamsters by metformin, Gastroenterology, vol.120, issue.5, pp.1263-1270, 2001. ,
DOI : 10.1053/gast.2001.23258
Diet and tumor LKB1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo, Oncogene, vol.62, issue.10, pp.1174-1182, 2010. ,
DOI : 10.1158/1940-6207.CAPR-08-0081
Tumours with PI3K activation are resistant to dietary restriction, Nature, vol.42, issue.7239, pp.725-731, 2009. ,
DOI : 10.1038/nature07782
Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Exp Gerontol, vol.40, pp.685-693, 2005. ,
Important role of the LKB1???AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice, Biochemical Journal, vol.412, issue.2, pp.211-221, 2008. ,
DOI : 10.1042/BJ20080557
Metformin suppresses intestinal polyp growth in ApcMin/+ mice, Cancer Science, vol.333, issue.11, pp.2136-2141, 2008. ,
DOI : 10.1111/j.1349-7006.2008.00933.x
Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells, Cancer Research, vol.67, issue.22, pp.10804-10812, 2007. ,
DOI : 10.1158/0008-5472.CAN-07-2310
In vitro metformin anti-neoplastic activity in epithelial ovarian cancer, Gynecologic Oncology, vol.110, issue.2, pp.246-250, 2008. ,
DOI : 10.1016/j.ygyno.2008.04.008
Metformin Is an AMP Kinase-Dependent Growth Inhibitor for Breast Cancer Cells, Cancer Research, vol.66, issue.21, pp.10269-10273, 2006. ,
DOI : 10.1158/0008-5472.CAN-06-1500
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation, Blood, vol.116, issue.20, pp.4262-4273, 2010. ,
DOI : 10.1182/blood-2010-02-269837
Thiazolidinediones Inhibit Insulin-Like Growth Factor-I-Induced Activation of p70S6 Kinase and Suppress Insulin-Like Growth Factor-I Tumor-Promoting Activity, Cancer Research, vol.66, issue.3, pp.1873-1878, 2006. ,
DOI : 10.1158/0008-5472.CAN-05-3111
Metformin Disrupts Crosstalk between G Protein-Coupled Receptor and Insulin Receptor Signaling Systems and Inhibits Pancreatic Cancer Growth, Cancer Research, vol.69, issue.16, pp.6539-6545, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-0418
AMP-activated protein kinase activators can inhibit the growth of prostate cancer cells by multiple mechanisms, Biochemical and Biophysical Research Communications, vol.321, issue.1, pp.161-167, 2004. ,
DOI : 10.1016/j.bbrc.2004.06.133
Targeting AMP-activated protein kinase in adipocytes to modulate obesity-related adipokine production associated with insulin resistance and breast cancer cell proliferation, Diabetology & Metabolic Syndrome, vol.3, issue.1, p.16, 2011. ,
DOI : 10.1677/JME-09-0063
AMP-activated protein kinase inhibits NF-kappaB signaling and inflammation: impact on healthspan and lifespan, J, 2011. ,
Metformin inhibits inflammatory angiogenesis in a murine sponge model, Biomedicine & Pharmacotherapy, vol.64, issue.3, pp.220-225, 2010. ,
DOI : 10.1016/j.biopha.2009.08.004
The effect of metformin treatment on VEGF and PAI-1 levels in obese type 2 diabetic patients, Diabetes Research and Clinical Practice, vol.81, issue.1, pp.56-60, 2008. ,
DOI : 10.1016/j.diabres.2008.02.006
The antidiabetic drug metformin suppresses HER2 (erbB-2) oncoprotein overexpression via inhibition of the mTOR effector p70S6K1 in human breast carcinoma cells, Cell Cycle, vol.8, issue.1, pp.88-96, 2009. ,
DOI : 10.4161/cc.8.1.7499
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level, Oncogene, vol.14, issue.25, pp.3576-3586, 2008. ,
DOI : 10.1172/JCI200113505
URL : https://hal.archives-ouvertes.fr/inserm-00277135
Metformin, Independent of AMPK, Induces mTOR Inhibition and Cell-Cycle Arrest through REDD1, Cancer Research, vol.71, issue.13, pp.4366-4372, 2011. ,
DOI : 10.1158/0008-5472.CAN-10-1769
Cell cycle arrest in Metformin treated breast cancer cells involves activation of AMPK, downregulation of cyclin D1, and requires p27<sup>Kip1</sup> or p21<sup>Cip1</sup>, Journal of Molecular Signaling, vol.3, p.18, 2008. ,
DOI : 10.1186/1750-2187-3-18
Dual antiglioma action of metformin: cell cycle arrest and mitochondria-dependent apoptosis, Cellular and Molecular Life Sciences, vol.64, issue.10, pp.1290-1302, 2007. ,
DOI : 10.1007/s00018-007-7080-4
Metformin induces unique biological and molecular responses in triple negative breast cancer cells, Cell Cycle, vol.8, issue.13, pp.2031-2040, 2009. ,
DOI : 10.4161/cc.8.13.8814
Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells, Molecular Cancer Research, vol.9, issue.5, pp.603-615, 2011. ,
DOI : 10.1158/1541-7786.MCR-10-0343
Targeting cancer cell metabolism: the combination of metformin and 2-deoxyglucose induces p53-dependent apoptosis in prostate cancer cells, 2010. ,
AMP-Activated Protein Kinase Induces a p53-Dependent Metabolic Checkpoint, Molecular Cell, vol.18, issue.3, pp.283-293, 2005. ,
DOI : 10.1016/j.molcel.2005.03.027
Systemic Treatment with the Antidiabetic Drug Metformin Selectively Impairs p53-Deficient Tumor Cell Growth, Cancer Research, vol.67, issue.14, pp.6745-6752, 2007. ,
DOI : 10.1158/0008-5472.CAN-06-4447
Hyperglycemia and Adverse Pregnancy Outcomes, Obstetric Anesthesia Digest, vol.29, issue.1, pp.1991-2002, 2008. ,
DOI : 10.1097/01.aoa.0000344706.95925.dc
Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study, Diabetic Medicine, vol.19, issue.8, 2009. ,
DOI : 10.1111/j.1464-5491.2009.02780.x
Metformin versus Insulin for the Treatment of Gestational Diabetes, New England Journal of Medicine, vol.358, issue.19, pp.2003-2015, 2008. ,
DOI : 10.1056/NEJMoa0707193
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin, N Engl J Med, vol.346, pp.393-403, 2002. ,
Crosstalk between Components of Circadian and Metabolic Cycles in Mammals, Cell Metabolism, vol.13, issue.2, pp.125-137, 2011. ,
DOI : 10.1016/j.cmet.2011.01.006
Activation of 5'-AMP-activated Kinase with Diabetes Drug Metformin Induces Casein Kinase I?? (CKI??)-dependent Degradation of Clock Protein mPer2, Journal of Biological Chemistry, vol.282, issue.29, pp.20794-20798, 2007. ,
DOI : 10.1074/jbc.C700070200
Metformin and the AMP-activated protein kinase . Metformin: mechanistic insights towards new applications . 81 -110 Transworld Research Network, 2008. ,
Metformin is a Superior Substrate for Renal Organic Cation Transporter OCT2 rather than Hepatic OCT1, Drug Metabolism and Pharmacokinetics, vol.20, issue.5, pp.379-386, 2005. ,
DOI : 10.2133/dmpk.20.379
Functional involvement of organic cation transporter1 (OCT1/Oct1) in the hepatic uptake of organic cations in humans and rats, Xenobiotica, vol.51, issue.8, pp.818-831, 2007. ,
DOI : 10.1038/372549a0
The Effects of Genetic Polymorphisms in the Organic Cation Transporters OCT1, OCT2, and OCT3 on the Renal Clearance of Metformin, Clinical Pharmacology & Therapeutics, vol.1, issue.3, pp.299-306, 2009. ,
DOI : 10.1086/319501
OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine, Pharmacogenetics and Genomics, vol.18, issue.7, 2008. ,
DOI : 10.1097/FPC.0b013e328302cd41
Pharmacogenetics of Anti-Diabetes Drugs, Pharmaceuticals, vol.3, issue.8, pp.2610-2646, 2010. ,
DOI : 10.3390/ph3082610
Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes, Nature Genetics, vol.352, issue.2, pp.117-120, 2011. ,
DOI : 10.1016/0014-5793(95)00172-6
Metformin attenuates the stimulatory effect of a high-energy diet on in vivo LLC1 carcinoma growth, Endocrine Related Cancer, vol.15, issue.3, 2008. ,
DOI : 10.1677/ERC-08-0038
Metformin Selectively Targets Cancer Stem Cells, and Acts Together with Chemotherapy to Block Tumor Growth and Prolong Remission, Cancer Research, vol.69, issue.19, pp.7507-7511, 2009. ,
DOI : 10.1158/0008-5472.CAN-09-2994
Metformin in chemically-induced mammary carcinogenesis in rats, Neoplasma, vol.56, issue.3, pp.269-274, 2009. ,
DOI : 10.4149/neo_2009_03_269
Metformin Prevents Tobacco Carcinogen-Induced Lung Tumorigenesis, Cancer Prevention Research, vol.3, issue.9, pp.1066-1076, 2010. ,
DOI : 10.1158/1940-6207.CAPR-10-0055
Metformin suppresses azoxymethane-induced colorectal aberrant crypt foci by activating AMP-activated protein kinase, Molecular Carcinogenesis, vol.57, issue.7, pp.662-671, 2010. ,
DOI : 10.1002/mc.20637
Metformin and cancer. From diabetes to cancer: New therapeutic perspectives for metformin . M decine des maladies M taboliques é é, pp.29-37, 2011. ,
Gastrointestinal polyps 250 mg/kg Oral ,